Cargando…

Comparison of Four SARS-CoV-2 Neutralization Assays

Neutralizing antibodies are a major correlate of protection for many viruses including the novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing antibodies to render effective protection from infection. A variety of in vitro assays for the detection of SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riepler, Lydia, Rössler, Annika, Falch, Albert, Volland, André, Borena, Wegene, von Laer, Dorothee, Kimpel, Janine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824240/ https://www.ncbi.nlm.nih.gov/pubmed/33379160 http://dx.doi.org/10.3390/vaccines9010013

Ejemplares similares

Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay
por: Borena, Wegene, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

Marked Increase in Avidity of SARS-CoV-2 Antibodies 7–8 Months After Infection Is Not Diminished in Old Age
por: Pichler, Daniel, et al.
Publicado: (2021)

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
por: Rössler, Annika, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak
por: Willeit, Peter, et al.
Publicado: (2022)

High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
por: Knabl, Ludwig, et al.
Publicado: (2021)

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
por: Rössler, Annika, et al.
Publicado: (2022)

Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity
por: Rössler, Annika, et al.
Publicado: (2022)

Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination
por: Harthaller, Teresa, et al.
Publicado: (2023)

Reduced sensitivity of antibody tests after omicron infection
por: Rössler, Annika, et al.
Publicado: (2023)

High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz
por: Harthaller, Teresa, et al.
Publicado: (2022)

Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
por: Borena, Wegene, et al.
Publicado: (2021)

12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2021)

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
por: Bánki, Zoltán, et al.
Publicado: (2022)

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria
por: Bánki, Zoltán, et al.
Publicado: (2022)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
por: Pipperger, Lisa, et al.
Publicado: (2021)

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
por: Seekircher, Lisa, et al.
Publicado: (2023)

Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants
por: Volland, André, et al.
Publicado: (2021)

Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout
por: Lichtenegger, Sabine, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases
por: Mack, Dietrich, et al.
Publicado: (2021)

Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme?
por: Borena, Wegene, et al.
Publicado: (2016)

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2020)

Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot
por: Paetzold, Jörg, et al.
Publicado: (2022)

Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies
por: Kreidl, Peter, et al.
Publicado: (2019)

Successful return to professional men’s football (soccer) competition after the COVID-19 shutdown: a cohort study in the German Bundesliga
por: Meyer, Tim, et al.
Publicado: (2021)

No molecular or serological evidence of Zikavirus infection among healthy blood donors living in or travelling to regions where Aedes albopictus circulates
por: Borena, Wegene, et al.
Publicado: (2017)

Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria
por: Lehmann, Jens, et al.
Publicado: (2021)

Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
por: Koske, Iris, et al.
Publicado: (2019)

Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020
por: Siller, Anita, et al.
Publicado: (2021)

The Role of HPV and Non-HPV Sexually Transmitted Infections in Patients with Oropharyngeal Carcinoma: A Case Control Study
por: Kofler, Barbara, et al.
Publicado: (2020)

Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021
por: Winner, Hannes, et al.
Publicado: (2022)

Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study
por: Willeit, Peter, et al.
Publicado: (2021)

N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro
por: Lackner, Michaela, et al.
Publicado: (2022)

Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma
por: Kofler, Barbara, et al.
Publicado: (2020)

Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum
por: Pipperger, Lisa, et al.
Publicado: (2019)

A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition
por: Heilmann, Emmanuel, et al.
Publicado: (2022)

A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants
por: Wagner, Gabriel E., et al.
Publicado: (2021)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
por: Kimpel, Janine, et al.
Publicado: (2018)

Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria
por: Borena, Wegene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bri1dfls546i52v4nba2q934rr